Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival
about
Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesityNew perspectives on exploitation of incretin peptides for the treatment of diabetes and related disordersPotential roles of GPR120 and its agonists in the management of diabetesTcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 β-cell lineCholecystokinin and pancreatic cancer: the chicken or the egg?Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in miceDiminished mTOR signaling: a common mode of action for endocrine longevity factors.A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells.Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cellsGlucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From ApoptosisCholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis.Gastrointestinal hormones and the regulation of β-cell mass.Recent advances in pancreatic endocrine and exocrine secretion.Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.Gut: A key player in the pathogenesis of type 2 diabetes?
P2860
Q26749198-93DD71F5-3587-449D-88E7-6EAACC5D484DQ26777654-39F9503A-95E6-4DEB-93F8-8FC6C334EB1EQ26827101-B234EDD1-D9BA-4D38-B98A-BB2D0D883565Q28510633-03BF7D63-A552-44F7-B632-BD61DAD86A73Q33816883-CA92DD51-4C70-4EC1-A6F3-93B92A7400DEQ33894658-DC953A46-388C-4089-96AF-E39C93FE46F4Q34167464-186C4609-534D-4923-AF21-AE4CB50BBE0DQ34462362-B4A57619-E197-4341-B192-0902602258EFQ35123539-4EB5AE53-8915-477A-A26F-3DEBF270A815Q35739137-6F054560-3C2F-4852-8383-F6A7EC7F6BCBQ35794958-724A2536-B7CA-4FB1-BC91-5B478353F698Q36297519-9B37FFBD-0DAA-471D-9E40-350AE745EABDQ37805600-8DEC19EF-C5B4-41FE-907B-08CF61BA70CFQ37903629-D3530C96-7D6C-4F59-A919-AEBC211D8DC0Q38304318-A8887092-4C8B-401C-9982-8246163B7428Q39021924-E500291F-D954-4A74-8D7C-6230511256E3
P2860
Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@ast
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@en
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@nl
type
label
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@ast
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@en
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@nl
prefLabel
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@ast
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@en
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@nl
P2093
P2860
P356
P1433
P1476
Cholecystokinin is up-regulate ...... increasing beta-cell survival
@en
P2093
Alan D Attie
Brian S Yandell
Dawn Belt Davis
Donald S Stapleton
James E Koltes
Jeremy A Lavine
John A Dawson
Joshua I Suhonen
Kathryn L Schueler
Linda C Samuelson
P2860
P304
P356
10.1210/EN.2010-0233
P407
P577
2010-06-09T00:00:00Z